poisar

Stock

Accuray Incorporated ARAY

$0.28+0.98%

Overview

ARAY market data

Price History

ARAY price chart

Valuation & Profitability

Provider-backed
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$0.02
Diluted earnings per share over the trailing twelve months.
Beta
1.45
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
-10.8%
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$0.22 – $2.10
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $33.4M · P/B 1.74 · P/S 0.08.

Company News

6 captured
12 Health Care Stocks Moving In Tuesday's After-Market SessionBenzinga · Aug 11, 2026, 9:06 PM
Reported Earlier, Accuray Reduces Board To 7 Directors, Plans Reverse Stock Split Alongside TCW-Led Financial RestructuringBenzinga · Jul 30, 2026, 8:15 AM
8-K filing — ACCURAY INC (ARAY)SEC EDGAR · Jul 29, 2026, 9:25 PM
Why Q32 Bio Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving PremarketBenzinga · Jul 13, 2026, 8:39 AM
Accuray shares are trading higher after the company announced a new 10‑year strategic collaboration to advance personalized cancer treatments using Accuray's Stellar adaptive radiation therapy platform.Benzinga · May 15, 2026, 9:00 PM
Accuray And The University of Wisconsin School of Medicine and Public Health Announce A New 10-Year Strategic Collaboration To Advance Personalized Cancer Treatments Using Accuray's Stellar Adaptive Radiation Therapy PlatformBenzinga · May 15, 2026, 8:24 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock